Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

01.12.2015 | short review | Ausgabe 4/2015

memo - Magazine of European Medical Oncology 4/2015

Gastric and esophageal cancer: Post ASCO 2015

Zeitschrift:
memo - Magazine of European Medical Oncology > Ausgabe 4/2015
Autor:
MD Ewald Wöll

Abstract

Immunologic tumor therapy was the leading theme of this year’s ASCO. In this context first results for check point inhibitors active in esophageal and gastric cancer were presented. Phase III trials involving c-met inhibitors however were not successful. First phase II results with regorafenib emphasize a potential role for TKI’s in gastric cancer.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 4/2015

memo - Magazine of European Medical Oncology 4/2015Zur Ausgabe